课题基金 / 基金详情

Disease Pathogenesis and Modification for CaV1.1-Associated Hypokalemic Periodic

Disease Pathogenesis and Modification for CaV1.1-Associated Hypokalemic Periodic
CaV1.1 相关低钾血症周期性疾病的发病机制和修饰
批准号:
9528467
负责人:
STEPHEN C. CANNON
金额:
$45.13万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2022-06-30

项目摘要

项目成果

STEPHEN C. CANNON的其他基金

相似基金

相关文献

中文摘要
翻译
低钾性周期性麻痹(HypoPP)是一种主要的遗传性骨骼肌疾病,其反复发作的虚弱是由纤维兴奋性间歇性失效引起的。发作与低钾血症(K+ < 3mm)有关,通常由碳水化合物摄入、运动或压力引起。HypoPP的分子缺陷具有异质性,60%的家族在编码l型钙通道CaV1.1的CACNA1S中存在错义突变,20%的家族在编码电压门控钠通道NaV1.4的SCN4A中存在错义突变。尽管取得了这一科学进展,但纤维去极化和兴奋性丧失的短暂发作的致病基础尚未完全确定,缺乏有效的临床干预措施。本研究旨在促进我们对CaV1.1 HypoPP突变引起的功能缺陷的理解,并将这些信息应用于模型模拟,以深入了解疾病机制,从而确定实验可测试的疾病修饰策略。NaV1.4中的所有10个HypoPP突变和CaV1.1中的11个突变中的9个发生在电压传感器结构域(VSD) S4段的精氨酸残基上。对于NaV1.4 HypoPP,这些R/X突变由于一个小的异常“门控孔电流”而使通道泄漏。通过同源性,已经提出了CaV1.1 HypoPP的类似缺陷,但实验证实有限。在本项目的前一个周期中,我们在我们的R528H敲入突变小鼠HypoPP模型中检测到CaV1.1门控孔电流。这一发现支持了一种观点,即异常门控孔电流是NaV1.4和CaV1.1 HypoPP突变通道之间的共同特征,从而解释了两种通道的突变如何产生相同的临床表型。CaV1.1-R528H小鼠具有强大的HypoPP表型,是研究环境触发导致兴奋性和虚弱丧失的机制的独特资源。例如,我们最近发现
英文摘要
Hypokalemic periodic paralysis (HypoPP) is a dominantly inherited disorder of skeletal muscle in which recurrent attacks of weakness are caused by intermittent failure of fiber excitability. Episodes occur in association with hypokalemia (K+ <3 mM) and are often triggered by carbohydrate ingestion, exercise, or stress. The molecular defect in HypoPP is heterogeneous, with 60% of families having missense mutations in CACNA1S encoding the L-type Ca channel CaV1.1, and 20% have missense mutations in SCN4A encoding the voltage-gated Na channel NaV1.4. Despite this scientific advance, the pathogenic basis for the transient attacks of fiber depolarization and loss of excitability is not fully established, and effective clinical interventions are lacking. The proposed studies are designed to advance our understanding of the functional defects caused by CaV1.1 HypoPP mutations and to apply this information in model simulations to gain insights on disease mechanism and thereby identify experimentally testable strategies for disease modification. All 10 HypoPP mutations in NaV1.4 and 9 of 11 in CaV1.1 occur at arginine residues in S4 segments of voltage-sensor domains (VSD). For NaV1.4 HypoPP, these R/X mutations make channels leaky because of a small anomalous “gating pore current”. By homology, a similar defect has been proposed for CaV1.1 HypoPP, but experimental confirmation has been limited. In the prior cycle of this project, we detected a CaV1.1 gating pore current in our R528H knockin mutant mouse model of HypoPP. This finding supports the notion that the anomalous gating pore current is a feature in common between NaV1.4 and CaV1.1 HypoPP mutant channels, and thereby explains how mutations of either channel can produce the same clinical phenotype. The CaV1.1-R528H mice have a robust HypoPP phenotype and are a unique resource for investigating mechanisms by which environmental triggers elicit loss of excitability and weakness. For example, we recently discovered that recovery from acidosis is a potent trigger for a transient loss of force in soleus muscle of R528H mice, which may provide the first insight on why attacks of weakness frequently occur after strenuous exercise in HypoPP patients. The availability of fully-differentiated HypoPP muscle fibers provides an excellent system to study excitation-contraction coupling, and Ca2+ release is markedly suppressed in homozygous R528H fibers. In other preliminary studies, we have achieved a 50-fold increase of CaV1.1 expression in Xenopus oocytes by co-expressing Stac3, a chaperone that promotes CaV trafficking to the membrane. This new high-expression system now makes it possible to determine whether the other CaV1.1 HypoPP mutations, especially the two atypical mutations not at R residues in S4, also support a gating pore current. The CaV1.1-R528H HypoPP mouse and the enhanced membrane expression of CaV1.1 in Xenopus oocytes will be used to address the following Specific Aims: (1) Test the hypothesis that an anomalous gating pore current is a pathomechanism in common with CaV1.1 mutations associated with HypoPP, (2) In the pH-shift model for post-exercise weakness in HypoPP, test the hypothesis that a shift in the Cl- gradient causes susceptibility to depolarization-induced loss of excitability and that maneuvers to limit Cl- accumulation reduce the severity of weakness. (3) Test whether impaired Ca2+ release is a pervasive defect in CaV1.1 R528H muscle and explore whether the defect is intrinsic to the channel mutation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiology of Myotonia and Periodic Paralysis
Pathophysiology of Myotonia and Periodic Paralysis
Pathophysiology of Myotonia and Periodic Paralysis
Disease Pathogenesis and Modification for CaV1.1-Associated Hypokalemic Periodic
海外基金